Key result
Non-invasive central aortic pressure independently predicts CV events and supports a ≥130/90 mmHg hypertension threshold.
Why the study?
The review aimed to outline the rationale and evidence supporting the incorporation of central aortic pressure monitoring into the care of patients with hypertension.
Does non-invasive central aortic pressure monitoring improve risk prediction and management in patients with hypertension?
Does non-invasive central aortic pressure monitoring improve risk prediction and management in patients with hypertension?
Non-invasive central aortic pressure monitoring provides superior or equivalent cardiovascular risk prediction compared to brachial pressure and can be incorporated into routine hypertension management.
Elevated central aortic pressure indices (e.g., systolic pressure and pulse pressure) predict cardiovascular (CV) events and mortality in addition to structural changes (e.g., left ventricular hypertrophy, carotid intima-media thickness and reduced glomerular filtration rate). These elevated risks have been shown in multiple studies to be superior to, and in others, at least as high as that associated with brachial pressures. Threshold values for the diagnosis of elevated central arterial pressures have been defined and can be considered target goals of treatment. Measurements of central arterial pressures can be incorporated into the current approaches to hypertension management utilizing currently available non-invasive devices that measure central pressures during the measurement of brachial BP. The objective of this review is to outline the rationale and evidence supporting incorporation of central aortic pressure monitoring into the care of patients with hypertension.
No takes yet. Share an insight, caveat, or question.
Kesten et al. (2022) conducted a review in Hypertension. Non-invasive central aortic pressure monitoring vs. Brachial blood pressure monitoring was evaluated. Non-invasive central aortic pressure monitoring provides independent predictive value for cardiovascular events and can be incorporated into hypertension management using a proposed threshold of ≥130/90 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: